The Technical Analyst
Statera Biopharma, Inc. [STAB]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Statera Biopharma, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0007
America/New_York / 25 apr 2024 @ 13:31
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0500 mill |
| EPS: | -2.36 |
| P/E: | 0 |
| Earnings Date: | Feb 12, 2024 |
| SharesOutstanding: | 71.42 mill |
| Avg Daily Volume: | 0.0254 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0007 - 0.0007 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-02-22 | Chandrasekhar Satishchandran | Buy | 0 | |
| 2021-09-09 | Saluck Randy S. | Buy | 60 000 | Common Stock, par value $0.005 per share |
| 2021-09-09 | Barbarick Steve K | Buy | 60 000 | Common Stock, par value $0.005 per share |
| 2021-09-09 | Verny Lea | Buy | 60 000 | Common Stock, par value $0.005 per share |
| 2021-09-28 | Markvicka Taunia | Buy | 100 000 | Common Stock, par value $0.005 per share |
| INSIDER POWER |
|---|
| 0.00 |
| Last 70 transactions |
| Buy: 2 421 695 | Sell: 3 004 967 |
Forecast:
15:11 - $0.0010
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0007 (0.00% ) |
| Volume | 0.0005 mill |
| Avg. Vol. | 0.0254 mill |
| % of Avg. Vol | 2.03 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For STAB
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
STAB
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
Last 10 Buy Signals
Latest Press Releases
2022-03-28 07:30:00 - Press Release
Statera Biopharma, Inc. To Report Fourth Quarter And Full Year 2021 Financial Results On March 31, 2022
Live conference call and webcast at 5:30 p.m. et
2021-11-09 07:32:00 - Press Release
Statera Biopharma, Inc. To Report Third Quarter 2021 Financial Results
Management to host conference call on monday, november 15, 2021, at 5:30 p.m. et management to host conference call on monday, november 15, 2021, at 5:30 p.m. et
2021-10-19 07:32:00 - Press Release
Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of Stat-205 For Acute Covid-19
Researchers at loma linda university health to evaluate p harmacokinetics, biomarkers and safety of stat-205
2021-10-06 07:33:00 - Press Release
Statera Biopharma, Inc. To Participate In The A.g.p. Biotech And Specialty Pharma Conference
Fort collins, colo., oct. 06, 2021 (globe newswire) -- statera biopharma, inc. (nasdaq: stab), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the company will participate in the alliance global partners (a.g.p.) biotech and specialty pharma conference taking place october 13, 2021.
2021-10-05 07:32:00 - Press Release
Statera Biopharma Announces Ceo Mike Handley To Speak During Virtual B & T Cell-mediated Autoimmune Disease Drug Development Summit
Fort collins, colo., oct. 05, 2021 (globe newswire) -- statera biopharma, inc. (nasdaq: stab), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that michael k. handley, president and chief executive officer, has been invited to participate as an expert speaker during the 2nd annual b & t cell-mediated autoimmune disease drug development summit. the virtual conference is taking place october 6-7, 2021.
Latest News
2022-10-06 11:41:32 - InvestorPlace
What Is Going on With Statera (STAB) Stock Today?
Source: Bukhta Yurii / Shutterstock.com Statera Biopharma (NASDAQ: STAB ) stock is rising higher on Thursday as the company holds a meeting with The Nasdaq Stock Market's Nasdaq Hearings Panel. The meeting with the Nasdaq Hearings Panel has to do with a delisting notice the company received for STAB shares.
2022-05-05 17:48:15 - PennyStocks
3 Penny Stocks That Pushed Up During Trading Today
Why these three penny stocks shot up during trading on May 5th The post 3 Penny Stocks That Pushed Up During Trading Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-05-03 14:48:34 - PennyStocks
Hot Penny Stocks To Buy For Under $1 This Week
Hot penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-04-30 11:30:00 - PennyStocks
Are These Penny Stocks Trading Strategies on Your List?
Are you using these trading strategies when you invest in penny stocks? The post Are These Penny Stocks Trading Strategies on Your List?
2022-04-28 14:50:20 - InvestorPlace
Why Is Statera Biopharma (STAB) Stock Up Today?
Today, investors in STAB stock have received a big boost as a a result of a signed commercialization agreement. The post Why Is Statera Biopharma (STAB) Stock Up Today?
2022-04-28 09:28:22 - PennyStocks
Hot Penny Stocks to Buy Today? 3 For Your List
Here's what you need to know about trading penny stocks on April 28th The post Hot Penny Stocks to Buy Today? 3 For Your List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-04-28 08:51:03 - Benzinga
Why Are Statera Biopharma Shares Surging Today
Statera Biopharma Inc (NASDAQ: STAB) has entered into a non-binding term sheet with Immune Therapeutics Inc (OTC: IMUN) to sell its naltrexone and met-enkephalin rights. The transaction is contingent upon the negotiation of a definitive agreement and satisfaction of.
2022-04-13 09:37:39 - PennyStocks
Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today
2022-03-28 07:30:00 - GlobeNewsWire
Statera Biopharma, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
2022-03-04 11:03:21 - PennyStocks
Trading Penny Stocks? Top Stock Market News for March 4th, 2022
What you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for March 4th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.